Warberg Asset Management LLC Virpax Pharmaceuticals, Inc. Transaction History

Warberg Asset Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.62 - $12.0 $1,240 - $24,000	-2,000 Reduced 10.52%	17,012 $10,000
Q3 2022 Nov 07, 2022	SELL	$1.15 - $11.9 $561 - $5,807	-488 Reduced 2.5%	19,012 $23,000
Q2 2022 Aug 11, 2022	BUY	$1.22 - $2.25 $2,183 - $4,027	1,790 Added 10.11%	19,500 $33,000
Q1 2022 May 13, 2022	BUY	$1.86 - $3.61 $32,940 - $63,933	17,710 New	17,710 $39,000

Ticker VRPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,714,600
Market Cap $7.97M
Description
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical no...

Get notified when there are updates to the investment portfolio of Warberg Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Warberg Asset Management LLC with notifications on news.